Fresenius SE & Co KGaA (FSNUY)
8.78
+0.16
(+1.86%)
USD |
OTCM |
Nov 15, 16:00
Fresenius Total Assets (Quarterly): 47.32B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 47.32B |
| June 30, 2024 | 46.64B |
| March 31, 2024 | 47.82B |
| December 31, 2023 | 50.06B |
| September 30, 2023 | 79.73B |
| June 30, 2023 | 83.04B |
| March 31, 2023 | 83.48B |
| December 31, 2022 | 81.93B |
| September 30, 2022 | 78.95B |
| June 30, 2022 | 79.51B |
| March 31, 2022 | 81.60B |
| December 31, 2021 | 81.48B |
| September 30, 2021 | 82.45B |
| June 30, 2021 | 82.89B |
| March 31, 2021 | 80.85B |
| December 31, 2020 | 81.97B |
| September 30, 2020 | 80.21B |
| June 30, 2020 | 78.23B |
| March 31, 2020 | 76.07B |
| December 31, 2019 | 75.06B |
| September 30, 2019 | 73.04B |
| June 30, 2019 | 73.82B |
| March 31, 2019 | 72.98B |
| December 31, 2018 | 64.86B |
| September 30, 2018 | 64.75B |
| Date | Value |
|---|---|
| June 30, 2018 | 63.57B |
| March 31, 2018 | 65.96B |
| December 31, 2017 | 63.74B |
| September 30, 2017 | 62.55B |
| June 30, 2017 | 60.51B |
| March 31, 2017 | 58.15B |
| December 31, 2016 | 49.37B |
| September 30, 2016 | 49.45B |
| June 30, 2016 | 48.74B |
| March 31, 2016 | 48.10B |
| December 31, 2015 | 46.97B |
| September 30, 2015 | 47.45B |
| June 30, 2015 | 47.41B |
| March 31, 2015 | 46.60B |
| December 31, 2014 | 48.38B |
| September 30, 2014 | 47.86B |
| June 30, 2014 | 48.44B |
| March 31, 2014 | 47.15B |
| December 31, 2013 | 45.23B |
| September 30, 2013 | 41.40B |
| June 30, 2013 | 40.37B |
| March 31, 2013 | 40.12B |
| December 31, 2012 | 40.55B |
| September 30, 2012 | 39.03B |
| June 30, 2012 | 38.27B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
46.64B
Minimum
Jun 2024
83.48B
Maximum
Mar 2023
73.96B
Average
79.97B
Median
Total Assets (Quarterly) Benchmarks
| Affimed NV | 57.00M |
| InflaRx NV | 89.00M |
| BioNTech SE | 25.02B |
| Immatics NV | 672.05M |
| CureVac NV | 596.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 25.65B |
| Shareholders Equity (Quarterly) | 21.03B |
| Debt to Equity Ratio | 0.6278 |
| Current Ratio | 1.356 |
| Net Debt Paydown Yield | 9.70% |